Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDUA | P35475 | 1/20 | 0.50 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.48 |
| ▸ | FGF2 | P09038 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | AHCY | P23526 | 1/20 | 0.31 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | GBA1 | P04062 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glucuronate SCHEMBL13324585 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL15596891 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL15177391 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL20094857 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL13376995 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL6404275 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL25253417 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL21792734 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL21312643 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 | |
| Glucuronate SCHEMBL6514487 | 1.00 | IDUA (0.50) | IDUASUCNR1FGF2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | claimed |
| US-11884961-B2 | DNA-glycan conjugates and methods of use | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2024-01-30 | — | — | US | claimed |
| CN-116626664-A | Radar shielding angle drawing method and device | 北京华如科技股份有限公司 | 2023-08-22 | — | — | CN | claimed |
| US-20260107172-A1 | METHOD, DEVICE AND COMPUTER STORAGE MEDIUM OF COMMUNICATION | NEC CORPORATION (JP) | 2026-04-16 | — | — | US | disclosed |
| EP-4668609-A1 | DEVICE AND METHOD FOR REPORTING CHANNEL STATE INFORMATION ON BASIS OF SUB-CONFIGURATIONS IN WIRELESS COMMUNICATION SYSTEM | LG Electronics Inc. (KR) | 2025-12-24 | — | — | EP | disclosed |
| US-20250361477-A1 | PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL | INBIOSE NV (BE) | 2025-11-27 | — | — | US | disclosed |
| EP-4608849-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | Inbiose N.V. (BE) | 2025-09-03 | — | — | EP | disclosed |
| US-20250188504-A1 | PRODUCTION OF A MIXTURE OF MAMMALIAN MILK OLIGOSACCHARIDES BY A CELL | INBIOSE N.V. (BE) | 2025-06-12 | — | — | US | disclosed |
| US-20250188503-A1 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2025-06-12 | — | — | US | disclosed |
| WO-2025093666-A1 | TREATMENT OF LYMPHOMA | UNIVERSITY OF COPENHAGEN (DK) | 2025-05-08 | — | — | WO | disclosed |
| CN-114503449-B | Method and apparatus for multiplexing partial channel state information | 三星电子株式会社 | 2025-04-18 | — | — | CN | disclosed |
| WO-2022034079-A2 | PROCESS FOR PURIFICATION OF AN OLIGOSACCHARIDE SOLUTION PRODUCED BY CELL CULTIVATION OR MICROBIAL FERMENTATION | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | disclosed |
| WO-2022034068-A1 | PRODUCTION OF A MIXTURE OF MAMMALIAN MILK OLIGOSACCHARIDES BY A CELL | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | disclosed |
| EP-3954769-A1 | PRODUCTION OF OLIGOSACCHARIDE MIXTURES BY A CELL | Inbiose N.V. (BE) | 2022-02-16 | — | — | EP | disclosed |
| WO-2021160830-A1 | GLYCOMINIMIZED BACTERIAL HOST CELLS | INBIOSE N.V. (BE) | 2021-08-19 | — | — | WO | disclosed |
| WO-2021160828-A1 | KDO-FREE PRODUCTION HOSTS FOR OLIGOSACCHARIDE SYNTHESIS | INBIOSE N.V. (BE) | 2021-08-19 | — | — | WO | disclosed |
| WO-2021160829-A1 | VIABLE BACTERIAL HOST CELL | INBIOSE N.V. (BE) | 2021-08-19 | — | — | WO | disclosed |
| WO-2021160827-A2 | PRODUCTION OF GLYCOSYLATED PRODUCT IN HOST CELLS | INBIOSE N.V. (BE) | 2021-08-19 | — | — | WO | disclosed |
| WO-2021074182-A1 | PRODUCTION OF BIOPRODUCT IN A HOST CELL | INBIOSE N.V. (BE) | 2021-04-22 | — | — | WO | disclosed |
| WO-2020245320-A1 | OPTIMAL CHROMOSOMAL INSERTION LOCI | INBIOSE N.V. (BE) | 2020-12-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260107172-A1 | METHOD, DEVICE AND COMPUTER STORAGE MEDIUM OF COMMUNICATION | TNNC1, TMCO1, DSP | IDUA 2383/4885SUCNR1 4672/4885FGF2 4096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.